Adama Materials Completes Series A Equity Financing

Adama Materials, Inc., a developer of nanotechnology-based advanced materials, announced today that it has completed a $4.75 million Series A equity financing led by Artiman Ventures, along with Startup Capital Ventures, the company's founders and a group of Hawaii-based angel investors including Cellular Bioengineering Inc.

The company also announced the appointment of Tim Dick from Startup Capital Ventures as chief executive officer and a member of the board of directors. Also appointed to the board are Amit Shah of Artiman Ventures and John Dean of Startup Capital Ventures. They join founder and chief technology advisor, Dr. Mehrdad Ghasemi Nejhad, graduate chair of the Department of Mechanical Engineering of the University of Hawaii (UH), Manoa. The company's co-founder, Donavan Kealoha, will serve as director of administration.

Adama Materials was founded when Kealoha, a graduate of UH's Shidler School of Business and the William S. Richardson School of Law, and Dr. Nejhad won first place and the technology prize at the 2008 UH business plan competition. Funded originally through grants from the United States Office of Naval Research, the company now has active projects with tier-one aerospace and composites companies and several patents.

"We welcome this investment and the addition of our new board members," said Dr. Nejhad. "It will allow commercialization of the technology Adama has developed over many years at UH, our long-term partner."

"We are delighted to achieve this financial milestone with Hawaii technology that leads the world in this field," said Dick. "It reflects the excitement in the market for the striking performance increases made possible by Adama's technology."

"Adama represents the ideal model of cross-disciplinary development of technology, business and law at UH, and demonstrates how UH discoveries can be successfully transferred to industry," said Jonathan Roberts of the UH Office of Technology Transfer and Economic Development.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.